Effects of aging on colony count and antibiotic susceptibility patterns of Escherichia coli isolated from male Wistar rats
Main Article Content
Abstract
Background
Physiological and immunological changes in the elderly may contribute to the composition and patterns of the gut microbiota, including Escherichia coli, as well as antimicrobial susceptibility patterns. The research was conducted to assess the effect of aging on Escherichia coli growth and susceptibility to several antibiotics.
Methods
An experimental laboratory study using 7 young (6-month-old) (YWR) and 7 old (24-month-old) Wistar rats (OWR) as subjects. Rat stool specimens were used as representing the subjects. Antibiotic susceptibility was determined using the Kirby-Bauer method. The independent t-test and Mann-Whitney test were used to analyse the data.
Results
All fecal specimens collected from both groups were positive for E. coli growth. The YWR showed a low density of E. coli, while the OWR showed a statistically significant increase in the population of E. coli (p=0.001). Overall, the E. coli isolates showed a high proportion of resistance to erythromycin (100%), ampicillin (86%), and oxytetracycline (58%). The isolates collected from YWR were significantly more resistant to streptomycin (83% vs. 19%, p<0.001) and tetracycline (47% vs. 3%, p<0.001) than the isolates from OWR. Young Wistar rats also had a higher resistance rate than OWR to the most frequently used antibiotics, such as ampicillin (97% vs. 76%, p<0.001).
Conclusion
Our study demonstrated an increase in the fecal E. coli population with increasing age of the Wistar rats. In addition, the results of susceptibility tests for several antibiotics showed that age may not be associated with an increase in the population of a resistant strain of E. coli.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
Kim S, Jazwinski SM. The gut microbiota and healthy aging: a mini-review. Gerontology 2018; 64:513–20. doi: 10.1159/000490615.
Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 2019;7:14. doi: 10.3390/microorganisms7010014.
Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Biotechnol 2015;33:496-503. doi: 10.1016 /j.tibtech.2015.06.011.
Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 2017;10:18-26. doi: 10.1038/mi.2016.75.
Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol 2021; 11:594150. doi: 10.3389/fimmu.2020.594150.
Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Cell 2015;14:309–21. doi: 10.1111/acel.12326.
Conway J, Duggal NA. Aging of the gut microbiome: potential influences on immune senescence and inflammaging. Ageing Res Rev 2021; 68:101323. doi: 10.1016/j.arr.2021.101323.
Mitchell SJ, Scheibye-Knudsen M, Longo DL, de Cabo R. Animal models of aging research: Implications for human aging and age-related diseases. Annu Rev Anim Biosci 2015;3:283–303. doi: 10.1146/annurev-animal-022114-110829.
Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009;53:2227–38. doi: 10.1128/AAC.01707-08.
Ju T, Willing B. Isolation of commensal Escherichia coli strains from feces of healthy laboratory mice or rats. Bio Protoc 2018;8:e2780. doi: 10.21769/BioProtoc.2780.
Huy HL, Koizumi N, Nuradji H, et al. Antimicrobial resistance in Escherichia coli isolated from brown rats and house shrews in markets, Bogor, Indonesia. J Vet Med Sci 2021; 83:531-4. doi: 10.1292/jvms.20-0558.
Anuwong TU, Biggel M, Cernela N, et al. Antimicrobial resistance and phylogenetic relatedness of extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli in peridomestic rats (Rattus norvegicus and Rattus tanezumi) linked to city areas and animal farms in Hong Kong, Environ Res 2024; 251,1: 118623. doi: 10.1016/j.envres.2024.118623.
Alimohamadi Y , Sepandi M. Sample size in animal studies. Iran J Med Microbiol 2022;16:173-6. Doi: 10.30699/ijmm.16.2.173.
Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med 2013;4:624-30.
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microb Infect 2012; 18:268–81. doi: 10.1111/j.1469-0691.2011. 03570.x.
Cho SY, Kim J, Lee JH, et al. Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice. Sci Rep 2016;6:39026. doi.org/ 10.1038/srep39026.
Klimova OM, Bozhkov AI, Kovalenkо TI, Minukhin VV, Belozorov IV. Young and old animals use different strategies for forming an immune response to infectious agents (Pseudomonas aeruginosa and Escherichia coli). Adv Gerontol 2018;31:330-8.
Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr 2016;4:10.1128/ microbiolspec.VMBF-0016-2015. doi: 10.1128/ microbiolspec.VMBF-0016-2015.
Blagojevic C, Brown KA, Diong C, et al. Long-term risk of infection among patients colonized with antimicrobial-resistant pathogens: a population-wide cohort study. Open Forum Infect Dis 2024;11:ofae712. doi: 10.1093/ofid/ofae712.
Rodríguez-Villodres Á, Martín-Gandul C, Peñalva G, et al. Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review. Antibiotics (Basel) 2021;10:680. doi: 10.3390/antibiotics10060680.
Husna A, Rahman MM, Badruzzaman ATM, et al. Extended-spectrum β-lactamases (ESBL): challenges and opportunities. Biomedicines 2023; 11:2937. doi: 10.3390/biomedicines11112937.
Shamsrizi P, Gladstone BP, Carrara E, et al. Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. BMJ Open 2020;10: e030266. doi: 10.1136/bmjopen-2019-030266.
Onanga R, Mbehang Nguema PP, Ndong Atome GR, et al. Prevalence of extended-spectrum β-lactamases in E. coli of rats in the Region North East of Gabon. Vet Med Int 2020:5163493. doi: 10.1155/2020/5163493.